Shattuck Labs Inc — Quarterly Financial Statistics (NASDAQ:STTK) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Cash from operating activities 16.07 M17.37 M12.03 M10.43 M8.93 M 48.76 M Cash from investing activities 821 K-31 M15.6 M012.29 M -3.11 M Cash from financing activities 23 K-72 K57 K044.38 M 44.37 M Free cash flow 16.02 M17.37 M12.03 M10.43 M8.93 M 48.76 M

Haberler

Piper Sandler, Shattuck Labs hissesini Ağırlık Üstü tavsiyesiyle takibe aldı

Piper Sandler initiates Shattuck Labs stock with Overweight rating

Shattuck Labs: "Hold" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot (STTK)

Earnings season to kick off with

Shattuck's Bowel Disease Treatment Looks Promising: Analyst - Shattuck Labs (NASDAQ:STTK)

H.C. Wainwright, Shattuck Labs hissesini Alım tavsiyesine yükseltti

Shattuck Labs stock rating upgraded to Buy by H.C. Wainwright

Shattuck Labs, Inc. (STTK) Presents at The United European Gastroenterology (UEG) Congress UEG Week 2025 Transcript

Shattuck Labs UEG Kongresi’nde: Yenilikçi IBD Tedavisi Hakkında Bilgiler

Shattuck Labs at UEG Congress: Innovative IBD Treatment Insights

What Makes Shattuck Labs, Inc. (STTK) a Strong Momentum Stock: Buy Now?

Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?